20558 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
DRUG CONTAINING CATIONIZED CHITOSAN
#302Composition having tissue-repairing activity, and use therefor
#303Compositions and methods for treating joints
#304Multiphasic compositions
#305Algal extract comprising sulphated and non-sulphated polyanionic polysaccharides and uses thereof
#306Anti-metastatic marine bacterial exopolysaccharide derivative and uses thereof
#307Combination of glycosaminoglycans and an antacid agent and compositions thereof
#308NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES
#309Cell Expansion Methods and Therapeutic Compositions
#310PHARMACEUTICAL COMPOSITIONS COMPRISING MODIFIED FUCANS AND METHODS RELATING THERETO
#311Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
#312Use of dextran sulfate
#313Protection of progenitor cells and regulation of their differentiation
#314Methods and compositions for the prevention and treatment of disease
#315Inhibitors of PCSK9 for treatment of lipoprotein metabolism disorders
#316Method of making a hydrolyzed collagen gel
#317Compositions and methods comprising growth factors, chondroitin and glucosamine for degenerative disc regeneration
#318COMPOSITION FOR TREATING BRAIN LESIONS
#319COMPOSITIONS AND METHODS FOR AQUACULTURE
#320Process for the preparation of polysaccharides
#321Composition for treating tissue lesions
#322Compositions and methods to affect skin irritation
#323SYNERGISTIC GLYCOCALYX TREATMENT COMPOSITIONS AND METHODS
#324SULPHATED XYLANS FOR TREATMENT OR PROPHYLAXIS OF RESPIRATORY DISEASES
#325Fast acting joint relief formulations
#326PHARMACEUTICAL COMPOSITIONS COMPRISING MODIFIED FUCANS AND METHODS RELATING THERETO
#327System for preparing medicinal beverages using cartridge-type beverage brewers
#328METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#329COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS
#330Treatment of bone marrow edema (oedema) with polysulfated polysaccharides
#331Method of producing collagen from hydrolyzed egg membrane
#332Sulphated hyaluronic acids as regulator agents of the cytokine activity
#333CARBOXYL CROSS-LINKED CHONDROITIN HYDROGELS AND THEIR USE FOR SOFT TISSUE APPLICATIONS
#334NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES
#335Compositions and methods for cell transplantation
#336Chondroitin sulfate derivative and agent for treating bladder diseases
#337LOCALLY RELEASED GROWTH FACTORS TO MEDIATE MOTOR RECOVERY AFTER STROKE
#338Composition for prevention or treatment of cutaneous disorder
#339APPARATUS AND FORMULATIONS FOR SUPRACHOROIDAL DRUG DELIVERY
#340COMPOSITIONS AND FORMULATIONS OF GLUCOSAMINE FOR TRANSDERMAL AND TRANSMUCOSAL ADMINISTRATION
#341Compositions and methods to affect skin irritation
#342Compositions and methods for treating joints
#343PHARMACEUTICAL COMPOSITIONS AND METHODS RELATING TO INHIBITING FIBROUS ADHESIONS OR INFLAMMATORY DISEASE USING LOW SULPHATE FUCANS
#344PHARMACEUTICAL COMPOSITIONS AND METHODS RELATING TO INHIBITING FIBROUS ADHESIONS OR INFLAMMATORY DISEASE USING LOW SULPHATE FUCANS
#345Stabilized Glycosaminoglycan Preparations and Related Methods
#346DEVICE AND METHOD TO TREAT OR PREVENT JOINT DEGENERATION
#347Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives
#348VISCOSUPPLEMENT COMPOSITION COMPRISING ULVAN FOR TREATING ARTHRITIS
#349COMPOSITION FOR ARTHRITIS, MOBILITY AND DELAY AGEING
#350Pharyngeal or buccal cavity rinse and process of use thereof
#351Polymeric materials including a glycosaminoglycan networked with a polyolefin-containing polymer
#352COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES AND CONDITIONS EMPLOYING ORAL ADMINISTRATION OF SODIUM PENTOSAN POLYSULFATE AND OTHER PENTOSAN POLYSULFATE SALTS
#353Chlorophyll c containing degranulation suppressor
#354Compositions and methods to affect skin irritation
#355THERAPEUTIC AGENT FOR KERATOCONJUNCTIVE DISORDER
#356PERSONALIZED TREATMENT OF CANCER USING FGFR INHIBITORS
#357METHODS OF GENERATING, REPAIRING AND/OR MAINTAINING CONNECTIVE TISSUE IN VIVO
#358Combination of an oxidant and a photoactivator for the healing of wounds
#359Methods for treating neurological conditions and compositions and materials therefor
#360Modulating the production of neurons and/or oligodendrocytes from white matter progenitor cells
#361VE-CADHERIN BINDING BIOCONJUGATE
#362Medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity
#363REGULATORS OF ANAPLASTIC LYMPHOMA KINASE AND USES THEREOF
#364Composition for Prevention and Treatment of Joint Pain and the Method of Preparation Thereof
#365Pharmaceutical compositions composed of low molecular weight sulfated hyaluronan
#366Fast acting joint relief formulations
#367Glycosaminoglycan composition and method of use for kidney stone removal
#368Methods and compositions for treating rosacea
#369Combination of a hyaluronic acid and of a sulphated polysaccharide
#370Compositions and methods for cell transplantation
#371Protection of progenitor cells and regulation of their differentiation
#372Combination of glycosaminoglycans and cyclodextrins
#373Bone and joint protection composition and use thereof
#374NOVEL INTERSTITIAL THERAPY FOR IMMEDIATE SYMPTOM RELIEF AND CHRONIC THERAPY IN INTERSTITIAL CYSTITIS
#375Polysaccharides from prasinococcales
#376Ionic aqueous polysaccharide compositions
#377Glycosaminoglycans
#378Sulfated polygulonic acid polysaccharide or pharmaceutical salt thereof, preparation method therefor and use thereof
#379Modulation of the physical interaction between platelets and the cell surface effecting cell proliferation
#380Multiple dose pharmaceutical compositions containing heparin and/or heparin-like compounds and devices and methods for delivering the same
#381Applications of partially and fully sulfated hyaluronan
#382Methods for the production of biopolymers with defined average molecular weight
#383Uridine diphosphate compounds as mobilizers of hematopoietic progenitor cells
#384Composition and method of use for combinations of anti-viral protease, polymerase inhibitors and natural bioactive compounds in the treatment of hepatitis C infection
#385Method of diagnosis, prognostic or treatment of neurodegenerative disease
#386BIOCONJUGATES AND USES THEREOF
#387Composition effective against viral conjunctivitis
#388Modification of bioabsorbable stent to reduce thrombogenecity
#389Synergistic glycocalyx treatment compositions and methods
#390Aminofucoidan as a vector for fibrinolysis in thrombotic diseases
#391Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof
#392COMPOSITION FOR BODY FAT CONSUMPTION
#393Derivatives of N-desulfated glycosaminoglycans and use as drugs
#394Cartilage product
#395Composition for tissue/cell repair
#396Compositions comprising sulfated polysaccharides and uses thereof
#397Compositions and methods for treating joints
#398Fucoidan nanogels and methods of their use and manufacture
#399DRUG CONTAINING CATIONIZED CHITOSAN
#400COHESIVE LIQUID BOLUS COMPRISING MOLECULES PROVIDING VISCO-ELASTICITY
#401Inhibitors of ADAMTS4 or ADAMTS5 for use in preventing or treating cardiac remodeling and chronic heart failure
#402NUTRACEUTICAL COMPOSITION AND METHODS FOR PREVENTING OR TREATING MULTIPLE SCLEROSIS
#403Use of dextran sulfate
#404TAPE HAVING TRANSDERMAL ANALGESIC PROPERTIES
#405Dextran sulfate for use in mobilization of cells
#406Heparan sulphates
#407Biotechnological sulphated chondroitin sulphate at position 4 or 6 on the same polysaccharide chain, and process for the preparation thereof
#408Hybrid cooperative complexes of hyaluronic acid
#409Low-Molecular-Weight Biotechnological Chondroitin 6-Sulphate for Prevention of Osteoarthritis
#410Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#411Fast acting joint relief formulations
#412Nutritional Supplement to Complement Cancer Therapy
#413Microbial-derived chondroitin sulfate
#414Nutritional supplement/feed formula and methods of use thereof to reduce development of Osteochondrosis Dissecans (OCD) lesions
#415Conjugate compound and uses of same
#416COMPOSITIONS AND METHODS TO ALTER GUT MICROBIAL FERMENTATION USING SULFATE-REDUCING BACTERIA
#417Compositions Containing Chondroitin Sulphate, Proteolytic Enzymes and Sulphydryl Compounds for Improving the Bioavailability of Chondroitin Sulphate
#418Methods for depyrogenating a seaweed extract
#419Composition having tissue-repairing activity, and use therefor
#420Sulfated depolymerized derivatives of exopolysaccharides (EPS) from mesophilic marine bacteria, method for preparing same, and uses thereof in tissue regeneration
#421FUCOIDAN NANOGELS AND METHODS OF THEIR USE AND MANUFACTURE
#422Sulphated polysaccharide composition
#423Glycosaminoglycans
#424ALGAL EXTRACT COMPRISING SULPHATED AND NON-SULPHATED POLYANIONIC POLYSACCHARIDES AND USES THEREOF
#425Oral combination for the prevention and treatment of bladder, pelvic and urogenital apparatus pathologies
#426Biodegradable microbead comprising anionic polymer for improving adsorptive power to anticancer drugs, and method for preparing same
#427Treatment of bone marrow edema (oedema) with polysulfated polysaccharides
#428Compositions and formulations of glucosamine for transdermal and transmucosal administration
#429Methods for treating neurological conditions and compositions and materials therefor
#430Media for culturing, preserving, and administering regenerative cells
#431Nano-targeted delivery of protease, polymerase inhibitors with or without immune modulators in the treatment of hepatitis C
#432Compositions for oral administration to animals, production methods thereof and uses of same
#433COMPOSITIONS AND METHODS FOR ENHANCING MOBILIZATION AND PROLIFERATION OF BLASTOMERE-LIKE STEM CELLS
#434COMPOSITION AND METHOD FOR PROMOTING JOINT AND BONE HEALTH
#435Method and composition of glycosaminoglycans in sickle cell and vascular disorders
#436LOW-LEVEL LASER IRRADIATION OF STIMULATED HUMAN STEM CELLS
#437INHIBITION OF TNF-ALPHA INDUCED ACTIVATION OF NFKB BY PENTOSAN POLYSULFATE
#438Composition comprising extract of mixture of sporophylls and ascidian shells for treating atopic dermatitis
#439Multi-layered anti-adhesion device
#440Extracorporeal devices and methods of treating complications of pregnancy
#441Polysaccharides from prasinococcales
#442Pharmaceutical removal of neuronal extensions from a degenerating disc
#443ANTIVIRAL COMPOSITIONS AND METHODS OF THEIR USE
#444Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives
#445Method for reducing the allergenicity of animal dander
#446METHOD FOR TREATMENT OF LABOR ARREST
#447NUTRACEUTICAL MODULATORS OF STEM CELL ACTIVITY
#448COMBINATION TREATMENT COMPRISING SULPHATED GLYCOSAMINOGLYCANS FOR INDUCING LABOR
#449Composition and method for treating connective tissue damage
#450USE OF LIPID CONJUGATES IN THE TREATMENT OF DISEASES
#451Process for perparing fondaparinux sodium and intermediates useful in the synthesis thereof
#452Compositions prepared from poultry and methods of their use
#453METHODS AND COMPOSITIONS FOR INCREASING RNA INTERFERENCE
#454METHOD OF PRODUCING COLLAGEN FROM HYDROLYZED EGG MEMBRANE
#455RAPID TWO-STEP SYNTHESIS OF ANTI-COAGULANTS
#456COMPOSITION FOR ENHANCING INTESTINE METABOLISM
#457COMPOSITION FOR BODY FAT CONSUMPTION
#458Stabalized glycosaminoglycan preparations and related methods
#459COMPOSITIONS AND METHODS FOR TREATING JOINTS
#460Methods for treating or preventing urological inflammation
#461Compositions for oral administration to animals, processes for obtaining the same and the uses thereof
#462Use of foti to enhance stem cell mobilization and proliferation
#463Chlorophyll c containing degranulation suppressor
#464Methods for fucoidan purification from seaweed extracts
#465LIPID CONJUGATES IN THE TREATMENT OF CHRONIC RFHINOSINUSITIS
#466Cartilage production promoter and prophylactic or therapeutic agent for diseases associated with cartilage damage
#467Process for the preparation of highly O-sulfated, epimerized derivatives of K5 polysacchride and intermediates therein
#468Antidandruff Agent Sulfated Polysaccharides
#469Locally released growth factors to mediate motor recovery after stroke
#470METHODS, APPARATUS, AND COMPOUNDS FOR THE TREATMENT OF CENTRAL RETINAL VEIN OCCLUSION AND OTHER CONDITIONS
#471Cysteine Peptide-Containing Health Drink
#472MEDICAMENT FOR TREATING ANTERIOR EYE DISEASE COMPRISING REBAMIPIDE AND A TEAR-RETAINING AGENT
#473PHARMACEUTICAL COMPOSITIONS AND METHODS RELATING TO INHIBITING FIBROUS ADHESIONS OR INFLAMMATORY DISEASE USING LOW SULPHATE FUCANS
#474Inhibition of cancer metastasis
#475Agent for treating HTLV-I associated myelopathy
#476PPS for the prevention of potential adverse effects caused by CD3 specific binding domains
#477Sulphated hyaluronic acid for treating degenerative osteoarthritis
#478Method of increasing lean body mass
#479Methods and compositions for inhibiting cellular proliferation and surgical adhesion
#480Anti-TNF-α therapy for the mucopolysaccharidoses and other lysosomal disorders
#481Pluripotent therapeutic compositions and uses thereof
#482Tripartite Bioactive Composition Providing Anti-Oxidant and Anti-Inflammatory Effects with Immune System and Stem Cell Production Enhancement
#483Compositions and methods for inhibiting adhesion formation
#484PHARMACEUTICAL COMPOSITIONS AND METHODS RELATING TO INHIBITING FIBROUS ADHESIONS OR INFLAMMATORY DISEASE USING LOW SULPHATE FUCANS
#485PHARMACEUTICAL COMPOSITIONS COMPRISING MODIFIED FUCANS AND METHODS RELATING THERETO
#486Antiinfective composition
#487Glycosaminoglycan oral use and compositions
#488Use of dextran sulfate
#489Use of dextran sulfate
#490COMPOSITIONS AND METHODS FOR STABILIZED POLYSACCHARIDE FORMULATIONS
#491Oligosaccharide compounds
#492COLD INFUSION PROCESS FOR FORTIFYING CORN AND/OR SOYBEANS
#493Methods for Treating Bleeding Disorders
#494Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients
#495Glycosaminoglycan Composition and Method for Treatment and Prevention of Interstitial Cystitis
#496Methods of promoting neuronal outgrowth by gypican 2 that binds to receptor protein tyrosine phosphatase sigma
#497Sulfated depolymerized derivatives of exopolysaccharides (EPS) from mesophilic marine bacteria, method for preparing same, and uses thereof in tissue regeneration
#498Compositions and formulations of glucosamine for transdermal and transmucosal administration
#499Treatment of bone marrow edema (oedema) with polysulfated polysaccharides
#500Sulphated arabinogalactans, apiogalacturonans and sulphated heteroglycans for treating diseases caused by the influenza virus
#501Basement Membrane Compositions and Applications Thereof
#502Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof
#503Histone inhibition
#504Use of lipid conjugates in the treatment of conjunctivitis
#505Substance for preventing and improving arthritis
#506COMPOSITION AND METHOD FOR PROMOTING JOINT AND BONE HEALTH
#507Method for mass preparation of proteoglycan
#508Methods and compositions for treating bleeding disorders
#509COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION
#510Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
#511Metallo-lactoferrin-coenzyme compositions and methods for weight management
#512Metallo-lactoferrin-coenzyme compositions for detoxification support
#513Compositions and methods for modulation of vascular structure and/or function
#514Modulation of factor 11 expression
#515Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients
#516Composition and method for treating connective tissue damage
#517Method of reducing weight using composition containing fucoxanthin extract
#518Polysaccharide gel formulation having increased longevity
#519APPLICATIONS OF PARTIALLY AND FULLY SULFATED HYALURONAN
#520NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES
#521Chondroitin sulfate having decreased molecular weight and use thereof
#522Natural Means of Augmenting Endogenous Stem Cell Numbers
#523HYBRID COOPERATIVE COMPLEXES OF HYALURONIC ACID
#524HEPARAN SULFATE REPLACEMENT THERAPY
#525Cystitis treatment with high dose chondroitin sulfate
#526Complex obtained from hyaluronic acid or a salt thereof and chondroitin sulphate mixtures
#527Inhibition of TNF-α induced activation of NFKB by pentosan polysulfate
#528ANTI-INFLAMMATORY COMPOSITIONS FOR TREATING NEURO-INFLAMMATION
#529Methods for reducing pulmonary uptake of intravenously injected cells
#530Anti-aging formulations
#531Methods and compositions for enhancing stem cell mobilization
#532INHIBITION OF CATHEPSIN K ACTIVITY AND THE TREATMENT AND PREVENTION OF DISEASE
#533Biomaterial from Wharton's jelly umbilical cord
#534Glycosaminoglycans
#535Anti-viral formulations
#536Supplement for Strengthening the Muscles of a Human
#537DENDRITIC CELL IMMUNORECEPTOR AGONIST
#538NEW FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN
#539Composition for treatment of aesthenopia
#540Sulodexide for use in the treatment of pathologies wherein metalloproteinases are involved
#541ANTIVIRAL COMPOSITIONS AND METHODS OF THEIR USE
#542ANTI-INFLAMMATORY COMPOSITIONS FOR TREATING BRAIN INFLAMMATION
#543HYDROXYTYROSOL COMPOSITIONS FOR TREATMENT OF CARTILAGE INJURIES IN JOINTS
#544Compositions and methods for stabilized polysaccharide formulations
#545GLYCOSAMINOGLYCAN INHIBITORS
#546METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS
#547Modification of bioabsorbable stent to reduce thrombogenecity
#548Biotechnological sulphated chondroitin sulphate at position 4 or 6 on the same polysaccharide chain, and process for the preparation thereof
#549Depolymerized glycosaminoglycan from and preparation method thereof
#550Ophthalmic composition containing xanthan gum and amino acid
#551POLYMERIC MATERIALS INCLUDING A GLYCOSAMINOGLYCAN NETWORKED WITH A POLYOLEFIN-CONTAINING POLYMER
#552Of gastrointestinal health, immunity and performance by dietary intervention
#553PROCESS FOR THE PREPARATION OF HIGHLY O-SULFATED EPIMERIZED DERIVATIVES OF K5 POLYSACCHARIDE AND INTERMEDIATES THEREIN
#554AGENT FOR INTRA-ARTICULAR INJECTION
#555TREATMENT COMPOSITION AND METHOD
#556INJECTABLE COMPOSITIONS FOR INTRA-ARTICULAR USE COMBINING A VISCOSUPPLEMENTATION AGENT AND A FIBROBLAST GROWTH MEDIUM
#557Antiviral composition comprising a sulfated polysaccharide
#558FGF receptor-activating N-acyl octasaccharides, preparation thereof, and therapeutic use thereof
#559BI-MODAL HYALURONATE
#560FGF receptor-activating N-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof
#561KITS AND IMPROVED COMPOSITIONS FOR TREATING LOWER URINARY TRACT DISORDERS
#562Polysaccharide gel formulation having multi-stage bioactive agent delivery
#563Methods and compositions for in vitro and in vivo chondrogenesis
#564Compositions and methods for treating joints
#565Sulphated hyaluronic acid for treating degenerative osteoarthritis
#566Methods for treating neurological conditions and compositions and materials therefor
#567METHODS AND COMPOSITIONS USING ERGOTHIONEINE TO TREAT A VARIETY OF HEALTH RELATED FACTORS
#568Composition with anti-inflammatory, protein synthesizing, treatment of enzyme deficiency, activating genetic therapy and anti-cancer activity and methods of use
#569Methods for treating bleeding disorders using sulfated polysaccharides
#570Composition for Treating Dry Eye and Related Methods of Manufacture and Methods of Use
#571Medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity
#572NICOTINAMIDE COMPOSITIONS FOR TREATMENT OF SKIN DISEASES AND DISORDERS
#573Sulfated heptasaccharide and its use as an antithrombotic agent
#574SULFATED POLYSACCHARIDES HAVING ANTIPLASMODIAL ACTIVITY AND METHODS AND PRODUCTS FOR IDENTIFYING ANTIPLASMODIAL ACTIVITY
#575Sulphated hyaluronic acids as regulator agents of the cytokine activity
#576Agent for preventing adverse side effects of carcinostatic agent
#577Treatment of oral mucositis by administering an ionic complex of chitosan and a negatively charged polysaccharide selected from heparin, heparan sulfate and dextran sulfate
#578Lipid conjugates in the treatment of chronic rhinosinusitis
#579CARTILAGE PRODUCTION PROMOTER AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR DISEASES ASSOCIATED WITH CARTILAGE DAMAGE
#580Cystitis treatment with high dose chondroitin sulfate
#581COMPOSITIONS FOR PROTECTION AGAINST SUPERFICIAL VASODILATOR FLUSH SYNDROME, AND METHODS OF USE
#582Methods and compositions for inhibiting cellular proliferation and surgical adhesion
#583Polymeric fibers having tissue reactive members
#584Methods for treating interstitial cystitis
#585METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS
#586Composition for Treating Dry Eye and Related Methods of Manufacture and Methods of Use
#587PHARMACEUTICAL COMPOSITIONS CONTAINING FUCOIDAN FOR STIMULATING AND ACTIVATING OSTEOGENESIS
#588Extracorporeal devices and methods of treating complications of pregnancy
#589Compositions containing fucoxanthin extract
#590Compounds and combinations
#591PHARMACEUTICAL COMPOSITION OF COMPLEX CARBOHYDRATES AND ESSENTIAL OILS AND METHODS OF USING THE SAME
#592Sulfated Galactans With Antithrombotic Activity, Pharmaceutical Composition, Method for Treating or Prophylaxis of Arterial or Venous Thrombosis, Method of Extraction and Use Thereof
#593Tissue matrix system
#594PHARMACEUTICAL COMPOSITIONS AND METHODS RELATING TO INHIBITING FIBROUS ADHESIONS OR INFLAMMATORY DISEASE USING LOW SULPHATE FUCANS
#595Sulfated depolymerized derivatives of expolysaccharides (EPS) from mesophilic marine bacteria, method for preparing the same, and uses thereof in tissue regeneration
#596Methods and compositions for treating bleeding disorders
#597Methods for treating bleeding disorders using sulfated polysaccharides
#598PREGNANE GLYCOSIDE COMPOSITIONS AND CARALLUMA EXTRACT PRODUCTS AND USES THEREOF
#599Use of lipid conjugates in the treatment of diseases
#600Combination of an oxidant and a photoactivator for the healing of wounds